I've noticed a lot of PR's in the pharmaceutical world as quite prejudiced toward the existing Big Pharma when competition is on the horizon of being introduced. As well the analysts really bend toward the existing brands.
Amag's female libido injectable therapy to sell at $899
BY Reuters
— 12:21 PM ET 08/06/2019
By Saumya Joseph
Aug 6 (Reuters) - Amag Pharmaceuticals Inc's ( AMAG
) treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for the condition.
The therapy, Vyleesi, was approved in June and will be available in September through the company's specialty pharmacy distribution network that would deliver the treatment to patients' homes.
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM